Fred Aslan sold $260K of Artiva Biotherapeutics (ARTV)

Executed Nov 2, disclosed Nov 3, 1 day later.

Value, as filed

$260K

62,178 sh × $4.18

Executed

Nov 2

the trade date, as filed

Disclosed

Nov 3

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Fred Aslan President and CEO profile →

Fred Aslan (President and CEO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Artiva Biotherapeutics, Inc. (ARTV). The largest single filing was $690K of ARTV (61,888 sh × $11.16, as filed), executed Sep 3.

The name

ARTV

Artiva Biotherapeutics, Inc. ARTV · Healthcare · 18 filings in 24 months ticker →

Healthcare · Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for pa…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Fred Aslan in ARTV

ARTVSALE Artiva Biotherapeutics, Inc. $169K
23,463 sh × $7.20
Exec Oct 6
Filed Oct 7 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $422K
61,696 sh × $6.84
Exec Oct 5
Filed Oct 6 · 4:01 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET